Market Exclusive

Analyst Activity – HC Wainwright Reiterates Buy on Acorda Therapeutics (NASDAQ:ACOR)

Analyst Ratings For Acorda Therapeutics (NASDAQ:ACOR)

Today, HC Wainwright reiterated its Buy rating on Acorda Therapeutics (NASDAQ:ACOR) with a price target of $31.00.

Some recent analyst ratings include


Recent Trading Activity for Acorda Therapeutics (NASDAQ:ACOR)
Shares of Acorda Therapeutics closed the previous trading session at 24.95 down -0.10 0.40% with 26699 shares trading hands.

Exit mobile version